Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and characterization of the cobas human papillomavirus test.

Journal of clinical microbiology - 1 May 2013

Rao Arundhati, Young Stephen, Erlich Henry, Boyle Sean, Krevolin Mark, Sun Rita, Apple Raymond, Behrens Catherine

Abstract excerpt

The cobas human papillomavirus (HPV) test, approved by the FDA in April 2011, is a fully automated assay for the detection of 14 high-risk (hr) HPV genotypes from cervical specimens collected in liquid-based cytology medium using real-time PCR amplification of the L1 gene and TaqMan probes. Results are simultaneously reported as positive or negative for the pooled 12 oncogenic HPV types (HPV31, -33, -35, -39,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Globins
Share to Cytodiagnosis
Share to Limit of Detection

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Sensitivity and Specificity

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23447640
DOI: 10.1128/JCM.03386-12
PMCID: PMC3647918

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and characterization of the cobas human papillomavirus test.PMID 23447640Read ↗

Cobas HPV test for first-line screening for cervical cancerSemantic proximity Read ↗

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV TestSemantic proximity Read ↗

Comparison of the cobas Human Papillomavirus (HPV) Test with the Hybrid Capture 2 and Linear Array HPV DNA TestsSemantic proximity Read ↗

Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection.Semantic proximity Read ↗

A direct comparison of four high risk human papilloma virus tests versus the cobas test for detecting cervical intraepithelial neoplasia and cervical cancerSemantic proximity Read ↗

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.Semantic proximity Read ↗

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.Semantic proximity Read ↗

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.Semantic proximity Read ↗

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.Semantic proximity Read ↗

Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.Semantic proximity Read ↗

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytologySemantic proximity Read ↗

High-Risk Human Papillomavirus Detection via Cobas® 4800 and REBA HPV-ID® Assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.